Suministro de medicamentos exclusivos: Ruxolitinib (Jakavi), Trametinib (Mekinis), Dabrafenib (Tafinlar), Nilotinib (Tasigna), Pazopanib (Votrient) y Ceritinib (Zykadia). Prórroga P.N.S.P. 5/2020.

Contract type	Supplies
CPV	33600000
Awarded to	Novartis Farmacéutica, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.